Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Astrana Health, Inc. (ASTH : NSDQ)
 
 • Company Description   
Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif.

Number of Employees: 1,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $24.81 Daily Weekly Monthly
20 Day Moving Average: 494,914 shares
Shares Outstanding: 56.29 (millions)
Market Capitalization: $1,396.52 (millions)
Beta: 0.87
52 Week High: $39.97
52 Week Low: $20.12
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.86% 9.05%
12 Week -18.44% -19.76%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1668 S. GARFIELD AVENUE 2ND FLOOR
-
ALHAMBRA,CA 91801
USA		 ph: 626-282-0288
fax: 818-839-5190		 investors@astranahealth.com http://www.astranahealth.com
 
 • General Corporate Information   
Officers
Brandon K. Sim - Chief Executive Officer and President
Kenneth Sim - Executive Chairman; Director
Thomas Lam - Vice Chairman; Director
Chandan Basho - Chief Financial and Operating Officer
John Vong - Chief Accounting Officer

Peer Information
Astrana Health, Inc. (CMTI)
Astrana Health, Inc. (CMWLQ)
Astrana Health, Inc. (AHG.)
Astrana Health, Inc. (ROIX)
Astrana Health, Inc. (M.DCE)
Astrana Health, Inc. (DHSM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-OUTP/HM CRE
Sector: Medical
CUSIP: 03763A207
SIC: 8742
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/26/26
Share - Related Items
Shares Outstanding: 56.29
Most Recent Split Date: (:1)
Beta: 0.87
Market Capitalization: $1,396.52 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.29 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.19 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 33.66% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/26/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.79
Trailing 12 Months: 130.58
PEG Ratio: 0.62
Price Ratios
Price/Book: 1.76
Price/Cash Flow: 16.72
Price / Sales: 0.48
EPS Growth
vs. Year Ago Period: -96.97%
vs. Previous Quarter: -94.74%
Sales Growth
vs. Year Ago Period: 99.71%
vs. Previous Quarter: 46.00%
ROE
12/31/25 - -
09/30/25 - 1.26
06/30/25 - 3.43
ROA
12/31/25 - -
09/30/25 - 0.60
06/30/25 - 1.87
Current Ratio
12/31/25 - -
09/30/25 - 1.40
06/30/25 - 1.59
Quick Ratio
12/31/25 - -
09/30/25 - 1.40
06/30/25 - 1.59
Operating Margin
12/31/25 - -
09/30/25 - 0.33
06/30/25 - 1.04
Net Margin
12/31/25 - -
09/30/25 - 0.33
06/30/25 - 1.04
Pre-Tax Margin
12/31/25 - -
09/30/25 - 1.04
06/30/25 - 2.12
Book Value
12/31/25 - -
09/30/25 - 14.07
06/30/25 - 13.76
Inventory Turnover
12/31/25 - -
09/30/25 - -
06/30/25 - -
Debt-to-Equity
12/31/25 - -
09/30/25 - 1.27
06/30/25 - 0.52
Debt-to-Capital
12/31/25 - -
09/30/25 - 49.31
06/30/25 - 17.83
 

Powered by Zacks Investment Research ©